Menu
  • The Barrow Neuroplex
  • Find a Doctor
  • International Patients
  • Contact Us
  • Patients & Families
  • Education
  • Research
  • Departments & People
  • News & Stories
  • Transfer a Patient
  • Fluid Biomarkers with Deep Phenotyping in Patients with ALS

    Fluid Biomarkers with Deep Phenotyping in Patients with ALS

    Enrollment Information

    Call (602) 406-1466 or E-Mail [email protected]

    This study is being performed to provide researchers with clinical information, combined with a wide range of biospecimens, to help identify biomarkers associated with amyotrophic lateral sclerosis (ALS), and to assess therapeutic targets. Participants will be asked to participate in four clinic visits and three telephone follow-up calls.

    At each clinic visit, participants will have blood (including DNA and RNA) collected and will be evaluated with assessment tools focusing on motor neuron and cognitive (memory and thinking) functions.

    Of the four visits in this study, three will also involve the collection of cerebrospinal fluid (CSF), and two will involve magnetic resonance imaging (MRI) cytography (a type of noninvasive body scan). Overall, participants may be in the research study for about 18 months.

    Principal Investigator: Shafeeq Ladha, MD

    Enrollment Contact
    Jessie Duncan
    (602) 406-1466
    [email protected]

    About Barrow Neurological Institute

    Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.